411 The miR-106b-25 Cluster as a Potential Target for Six1-mediated Breast Cancer Metastasis, and a Molecular Marker of the TGFβ Paradox

J.M. Vernier, D. Matthews, P. Pearson, S. Hershenson, J. Freddo, A.J. Giaccia, R. Tabibiazar, P.M. O’Connor. Ruga Corporation, Chemistry, Palo Alto California, USA; Ruga Corporation, Crystallography, Palo Alto California, USA; Ruga Corporation, Preclinical Development, Palo Alto California, USA; Ruga Corporation, Pharmaceutics, Palo Alto California, USA; Ruga Corporation, Clinical Development, Palo Alto California, USA; Stanford University School of Medicine, Department of Radiation Oncology, Stanford California, USA; Ruga Corporation, CEO, Palo Alto California, USA; Ruga Corporation, Research & Development, Palo Alto California, USA